Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.63 - $21.74 $28,648 - $35,327
-1,625 Reduced 5.37%
28,662 $565,000
Q4 2023

Feb 13, 2024

SELL
$14.37 - $19.07 $19,528 - $25,916
-1,359 Reduced 4.29%
30,287 $531,000
Q3 2023

Nov 14, 2023

SELL
$13.62 - $20.2 $44,728 - $66,336
-3,284 Reduced 9.4%
31,646 $549,000
Q2 2023

Aug 21, 2023

SELL
$10.44 - $16.48 $41,279 - $65,161
-3,954 Reduced 10.17%
34,930 $491,000
Q1 2023

May 09, 2023

SELL
$10.7 - $15.79 $5,317 - $7,847
-497 Reduced 1.26%
38,884 $418,000
Q4 2022

Feb 14, 2023

BUY
$11.42 - $17.05 $6,178 - $9,224
541 Added 1.39%
39,381 $589,000
Q3 2022

Nov 18, 2022

SELL
$9.76 - $13.41 $5,856 - $8,046
-600 Reduced 1.52%
38,840 $499,000
Q2 2022

Aug 15, 2022

BUY
$7.6 - $11.41 $38,228 - $57,392
5,030 Added 14.62%
39,440 $382,000
Q1 2022

May 16, 2022

SELL
$9.3 - $12.37 $18,460 - $24,554
-1,985 Reduced 5.45%
34,410 $342,000
Q4 2021

Feb 15, 2022

BUY
$10.39 - $15.15 $10,275 - $14,983
989 Added 2.79%
36,395 $428,000
Q3 2021

Nov 15, 2021

SELL
$11.39 - $16.23 $54,968 - $78,325
-4,826 Reduced 12.0%
35,406 $403,000
Q2 2021

Aug 16, 2021

SELL
$13.22 - $19.09 $1,031 - $1,489
-78 Reduced 0.19%
40,232 $560,000
Q1 2021

May 18, 2021

SELL
$16.68 - $23.97 $2,435 - $3,499
-146 Reduced 0.36%
40,310 $746,000
Q3 2020

Nov 17, 2020

BUY
$15.21 - $25.53 $179,249 - $300,871
11,785 Added 41.1%
40,456 $620,000
Q2 2020

Aug 17, 2020

BUY
$15.08 - $26.0 $107,264 - $184,938
7,113 Added 32.99%
28,671 $731,000
Q1 2020

May 13, 2020

BUY
$11.0 - $19.76 $2,728 - $4,900
248 Added 1.16%
21,558 $334,000
Q4 2019

Feb 14, 2020

SELL
$5.24 - $12.96 $896 - $2,216
-171 Reduced 0.8%
21,310 $236,000
Q2 2019

Aug 14, 2019

BUY
$13.2 - $20.39 $41,144 - $63,555
3,117 Added 16.97%
21,481 $291,000
Q1 2019

May 09, 2019

BUY
$15.93 - $26.59 $136,328 - $227,557
8,558 Added 87.27%
18,364 $332,000
Q3 2018

Nov 14, 2018

BUY
$13.23 - $30.93 $129,733 - $303,299
9,806 New
9,806 $250,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.